Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
7
×
eli lilly
7
×
fda
7
×
life sciences
national blog main
san francisco blog main
biotech
clinical trials
indiana blog main
national top stories
new york blog main
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
startups
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
investing
national
new york top stories
raleigh-durham top stories
san diego top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
amgen
bristol-myers squibb
cancer immunotherapy
genentech
medical device
pfizer
What
bio
roundup
cancer
diabetes
drug
drugs
fda
growing
pharmaceutical
wins
alliance
alzheimer’s
appetite
approval
approved
bails
beta
bionics
black
blood
blueprint
brand
bread
bridgebio
bristol
butter
buy
buyout
calls
candidate
capital
car
cash
changing
closed
color
companies
congress
crispr
currently
Language
unset
Current search:
fda
×
deals
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel